Literature DB >> 12524634

Borderline personality disorder in major depression: symptomatology, temperament, character, differential drug response, and 6-month outcome.

Peter R Joyce1, Roger T Mulder, Suzanne E Luty, Janice M McKenzie, Patrick F Sullivan, Robert C Cloninger.   

Abstract

Among 183 depressed patients participating in a randomized long-term treatment trial of fluoxetine and nortriptyline, 30 patients had borderline personality disorder (BPD), 53 had other personality disorders (OPD), and 100 had no personality disorders (NPD). The borderline depressed patients had earlier age of onset of their depressions, more chronic depressions, more alcohol and cannabis comorbidity, and were more likely to have histories of suicide attempts and of self-mutilation. On self-report, patients with BPD and OPD reported more phobic symptoms, greater interpersonal sensitivity, and more paranoid ideation. Uniquely, BPD patients were more angry than OPD patients. BPD patients had high novelty seeking, high harm avoidance, low self-directedness, and low cooperativeness. Depressed patients with BPD did poorly in the short term if treated with nortriptyline rather than fluoxetine. After 6 months, those with BPD had a favorable outcome in regard to depressive symptoms, social adjustment, and even improvement in the character measure of self-directedness. Those with the poorest outcome were those with OPD. Copyright 2003, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12524634     DOI: 10.1053/comp.2003.50001

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  14 in total

1.  Temperamental profiles of dysregulated children.

Authors:  Robert R Althoff; Lynsay A Ayer; Eileen T Crehan; David C Rettew; Julie R Baer; James J Hudziak
Journal:  Child Psychiatry Hum Dev       Date:  2012-08

Review 2.  Pharmacological interventions for antisocial personality disorder.

Authors:  Najat Khalifa; Conor Duggan; Jutta Stoffers; Nick Huband; Birgit A Völlm; Michael Ferriter; Klaus Lieb
Journal:  Cochrane Database Syst Rev       Date:  2010-08-04

Review 3.  Subthreshold bipolarity: diagnostic issues and challenges.

Authors:  Robin Nusslock; Ellen Frank
Journal:  Bipolar Disord       Date:  2011 Nov-Dec       Impact factor: 6.744

Review 4.  Borderline personality disorder and depression: an update.

Authors:  Maria Luca; Antonina Luca; Carmela Calandra
Journal:  Psychiatr Q       Date:  2012-09

5.  Evaluation of behavioral impulsivity and aggression tasks as endophenotypes for borderline personality disorder.

Authors:  Michael S McCloskey; Antonia S New; Larry J Siever; Marianne Goodman; Harold W Koenigsberg; Janine D Flory; Emil F Coccaro
Journal:  J Psychiatr Res       Date:  2009-02-18       Impact factor: 4.791

Review 6.  Temperament, character, and personality disorders in chronic pain.

Authors:  Rupert Conrad; Ingo Wegener; Franziska Geiser; Alexandra Kleiman
Journal:  Curr Pain Headache Rep       Date:  2013-03

Review 7.  Medications in the treatment of borderline personality disorder 2006.

Authors:  Deanna Mercer
Journal:  Curr Psychiatry Rep       Date:  2007-02       Impact factor: 8.081

8.  Standardization and normative data of the Greek version of the temperament and character inventory (TCI).

Authors:  Konstantinos N Fountoulakis; Sandor Rozsa; Melina Siamouli; Katerina Moutou; Eleonora Pantoula; Claude Robert Cloninger
Journal:  Ann Gen Psychiatry       Date:  2015-09-22       Impact factor: 3.455

9.  Genital self-mutilation in an attempt of suicide by a patient with a borderline personality.

Authors:  Rachid Aalouane; Ismail Rammouz; Hicham Hafidi; Saïd Boujraf
Journal:  J Neurosci Rural Pract       Date:  2013-04

10.  Pharmacological interventions for antisocial personality disorder.

Authors:  Najat R Khalifa; Simon Gibbon; Birgit A Völlm; Natalie H-Y Cheung; Lucy McCarthy
Journal:  Cochrane Database Syst Rev       Date:  2020-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.